JERUSALEM, May 23 /PRNewswire-FirstCall/ -- IDenta Corp. announced today it is in the final stages of introducing a new drug detection product that will identify the presence of Ketamine, a substance generally identified as a date rape drug. The new product is the first of several new products that IDenta is expected to introduce in the coming months.
"The Ketamine identifier is a product with broad applications in the civilian and consumer marketplaces, as well as with law enforcement agencies," reported IDenta CEO Yaacov Shoham. The date rape problem gained national attention in October of 1996 when Congress passed the Drug-Induced Rape Prevention and Punishment Act of 1996.
The act amended the Controlled Substances Act (CSA) to impose penalties of up to 20 years' imprisonment and a fine for violating CSA provisions by distributing a controlled substance to an individual without that individual's knowledge, with intent to commit a crime of violence (including rape) against that individual.
The new product will be made available in both the company's Stinger product line for professional use, as well as the Confirm product line for civilian and consumer use.
About Ketamine
Also known as Special K, Ketamine belongs to a class of drugs called "dissociative anesthetics," which separate perception from sensation. Ketamine usually comes as a liquid in small pharmaceutical bottles, and is most often cooked into a white powder for snorting. While low doses of Ketamine can increase heart-rate, at higher doses it depresses consciousness and breathing and is extremely dangerous to combine with depressents such as alcohol, Valium or GHB.
Ketamine can cause a tremendous psychological dependence. Frequent use can cause disruptions in consciousness and lead to neuroses or other mental disorders. The dissociation from one's consciousness experienced with ketamine can be highly seductive to some people, and there are many cases of ketamine addiction.
For further information see: http://www.dea.gov/concern/ketamine_factsheet.html
About IDenta
IDenta Corporation is one of the world's leading providers of proprietary on-site drug detection kits for governmental, professional and civilian use. Information concerning IDenta's business plan and product line, including rapid test kits (substance only) for the detection of marijuana, hashish, ecstasy, cocaine, crack, heroin and methamphetamines may be found at http://www.IDenta.biz and http://www.drugsdetector.com
For Investor Relations, lobbying interests or information concerning IDenta's products internationally contact:
Yaacov Shoham, IDenta Corp., CEO Tel: +972-52-6554487, +972-8-9716874 Fax: +972-8-9716875 fpi@drugsdetector.com For Investor Relations in the United States contact: Randy Jacobs, SITCOM LLC IDentaNews@sitcomllc.com +1-800-316-9437
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
IDenta Corp.CONTACT: For Investor Relations, lobbying interests or informationconcerning IDenta's products internationally contact: Yaacov Shoham, IDentaCorp., CEO, Tel: +972-52-6554487, +972-8-9716874, Fax: +972-8-9716875,fpi@drugsdetector.com. For Investor Relations in the United States contact:Randy Jacobs, SITCOM LLC, IDentaNews@sitcomllc.com, +1-800-316-9437
